Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
Medical Oncology,

Holgersson G et al. – The results indicate that standard haematological variables may be used as guidance for the clinician in the decision–making regarding treatment intensity and patient information.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Pemetrexed versus gefitinib as a second-line treatment in advanced non-squamous non-small-cell lung cancer patients harbouring wild-type EGFR (CTONG0806): A multicenter randomized trial Annals of Oncology, October 14, 2014    Clinical Article

2 Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial The Lancet, September 19, 2014    Evidence Based Medicine    Clinical Article

3 Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data The Lancet Oncology, September 24, 2014    Clinical Article

4 Systematic mediastinal lymphadenectomy or mediastinal lymph node sampling in patients with pathological stage I NSCLC: A meta-analysis World Journal of Surgery, October 13, 2014    Evidence Based Medicine

5 A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung Full Text BMC Cancer, October 10, 2014    Free full text    Clinical Article

6 A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer Annals of Oncology, October 8, 2014    Clinical Article

7 Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): A randomised, double-blind, phase 3 trial The Lancet Oncology, October 22, 2014    Clinical Article

8 Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial The Lancet Oncology, October 17, 2014    Clinical Article

9 Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly JAMA Surgery, October 23, 2014    Clinical Article

10 Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): An open-label, randomised, multicentre, phase 2 study The Lancet Oncology, October 3, 2014    Clinical Article

11 Experience with a CT screening program for individuals at high risk for developing lung cancer Journal of the American College of Radiology, October 21, 2014    Clinical Article

12 Is radical mediastinal lymphadenectomy necessary for elderly patients with clinical N0 non-small cell lung cancer? A single center matched-pair study Journal of Surgical Research, October 10, 2014    Clinical Article

13 Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: Randomized non-comparative phase IIIb NEXT trial Targeted Oncology, September 29, 2014    Clinical Article

14 Thermal ablation of malignant lung tumours Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, October 28, 2014    Review Article

15 A systemic inflammation-based prognostic score (mGPS) predicts overall survival in patients with small-cell lung cancer Tumor Biology, October 17, 2014    Clinical Article

16 Lung cancer probability in patients with CT-detected pulmonary nodules: A prespecified analysis of data from the NELSON trial of low-dose CT screening The Lancet Oncology, October 9, 2014    Clinical Article

17 Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody Clinical Cancer Research, September 26, 2014    Clinical Article

18 Association of cancer susceptibility variants with risk of multiple primary cancers: the Population Architecture using Genomics and Epidemiology study Cancer Epidemiology, Biomarkers & Prevention, September 10, 2014

19 Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA) Journal of Clinical Oncology, May 29, 2014    Clinical Article

20 Clinical analysis of chronic lung injury in patients with non-Hodgkin lymphoma after CHOP chemotherapy Tumor Biology, September 30, 2014    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore